- Acute Coronary Syndrome (ACS)
- Blood Clot
- Heart Attack
- Heart Block
- Heart Diseases
- Heart Failure
- High Blood Pressure (Hypertension)
- High Cholesterol
- High Cholesterol (Hypercholesterolemia)
- Unstable Angina
Over the years, he has developed a keen interest and expertise in the areas of cardiovascular genetics, sports cardiology, and cardio-oncology offering these advanced services to his patients to aid in their global treatment plans, allowing for an understanding of overlapping disease states and coordinating care across different specialties caring for the same patient.
Caring and Compassionate Approach
Dr. Espinoza prides himself on a caring and compassionate approach blended with the most advanced technology in medicine to treat his patients. Dr. Espinoza has worked with world renowned research institutes including Duke Clinical, Harvard Clinical and the National Institutes of Health, contributing to the advancement of cardiovascular medicine by contributing to the approvals of new oral anti-thrombotic drugs as alternatives to Coumadin and newer PCSK9 compounds that can dramatically reduce patient cholesterol levels especially when they cannot achieve goals on conventional therapies or cannot tolerate the commonly prescribed drugs, i.e. statins. He was involved in the first ever clinical trial for women evaluating stent grafting for abdominal aortic aneurysmal disease as well as the country’s first ever drug coated balloon trial for treatment of femoral popliteal in-stent restenosis disease.
Certifications and Honors
Dr. Espinoza is board certified in Cardiovascular Disease, Interventional Cardiology, and Endovascular Medicine. He is a scientific manuscript reviewer for the Journal Cardiac Catheterization and Intervention and resides on the Society of Cardiac Angiography and Interventions Carotid Committee. He also is a section member of the American College of Cardiology’s Peripheral Vascular Council and Cardio-Oncology division. He is a fellow of the American College of Cardiology and Fellow of the Society of Cardiac Angiography and Intervention.